Clinical trial
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using…
NCT00287235 · Vantive Health LLC, Industry · Completed
Key facts
| NCT number | NCT00287235 |
|---|---|
| Title | Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) |
| Official title | A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy |
| Lead sponsor | Vantive Health LLC, Industry |
| Collaborators | Gambro Renal Products, Inc. Industry Baxter Healthcare Corporation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatic Encephalopathy, Liver Failure, Hepatitis, Chronic, Liver Cirrhosis |
| Intervention type | Device, Drug |
| Interventions | MARS, Standard Medical Therapy |
| Enrollment | 70 |
| Start date | Sep 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | Feb 6, 2006 |
| Last update posted | Mar 3, 2025 |
| Countries | Belgium, Denmark, United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: